The relationship between CSF tau markers, hippocampal volume and delayed primacy performance in cognitively intact elderly individuals.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26258161)

Published in Alzheimers Dement (Amst) on March 01, 2015

Authors

Davide Bruno1, Michel J Grothe2, Jay Nierenberg3, Stefan J Teipel4, Henrik Zetterberg5, Kaj Blennow6, Nunzio Pomara3

Author Affiliations

1: Department of Psychology, Liverpool Hope University, Liverpool, UK.
2: German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany.
3: Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA ; Department of Psychiatry, School of Medicine, New York University, New York City, NY, USA.
4: German Center for Neurodegenerative Diseases (DZNE) - Rostock/Greifswald, Rostock, Germany ; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany.
5: Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden ; UCL Institute of Neurology, London, UK.
6: Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.

Articles cited by this

Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03

Memory--a century of consolidation. Science (2000) 12.95

Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology (1974) 7.34

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol (2010) 6.55

Hippocampal volume reduction in major depression. Am J Psychiatry (2000) 5.04

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain (2006) 3.95

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol (2009) 3.34

The psychology and neuroscience of forgetting. Annu Rev Psychol (2004) 3.20

Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry (2001) 3.07

Relationship between hippocampal volume and memory ability in healthy individuals across the lifespan: review and meta-analysis. Neuropsychologia (2004) 2.93

Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging (2008) 2.25

Alzheimer disease: are we intervening too late? Pro. J Neural Transm (Vienna) (2011) 2.15

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. Arch Gen Psychiatry (2011) 1.94

No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease. Brain (2007) 1.63

Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod (2013) 1.62

Amyloid-β associated volume loss occurs only in the presence of phospho-tau. Ann Neurol (2011) 1.44

Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am J Psychiatry (2012) 1.43

The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease. Neuroreport (1997) 1.38

Effect of parental family history of Alzheimer's disease on serial position profiles. Alzheimers Dement (2008) 1.32

Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiol Aging (2011) 1.32

CSF Abeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophy. J Alzheimers Dis (2008) 1.06

CSF tau markers are correlated with hippocampal volume in Alzheimer's disease. Neurobiol Aging (2011) 0.97

Decreased recall of primacy words predicts cognitive decline. Arch Clin Neuropsychol (2013) 0.89

Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia. J Neurol (2014) 0.87

Increased total TAU but not amyloid-beta(42) in cerebrospinal fluid correlates with short-term memory impairment in Alzheimer's disease. J Alzheimers Dis (2009) 0.85

A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals. Neuropsychologia (2015) 0.85

Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects. Alzheimers Dement (2014) 0.84

Hippocampal shape is predictive for the development of dementia in a normal, elderly population. Hum Brain Mapp (2013) 0.83

Serial position effects are sensitive predictors of conversion from MCI to Alzheimer's disease dementia. Alzheimers Dement (2014) 0.83

Serial position effects in mild cognitive impairment. J Clin Exp Neuropsychol (2010) 0.80